Aeolus Pharmaceuticals
Aeolus Pharmaceuticals completes $5M financing from new institutional investors
Published in Pharma Investments, Ventures and Law Weekly, July 9th, 2006
"The adverse role of free radicals in both acute and chronic disorders is well known," said Faiz Kayyem, managing partner at Efficacy Capital. "We believe that Aeolus' large pipeline of catalytic anti-oxidants will provide numerous development and partnership opportunities to address these disorders, which include stroke, ALS, cancer and Parkinson's Disease. We are pleased to have participated in this financing, which we believe will help the company to achieve significant clinical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly
More Articles from Pharma Investments, Ventures and Law Weekly
- Access Pharmaceuticals
Access Pharmaceuticals implements one for five reverse stock split - Aceto Corporation
Aceto to make investment in India by establishing new subsidiary - American Diabetes Association
Takeda commits $1.425 million to diabetes association's postdoctoral fellowship programs - BioMS Medical Corp.
BioMS Medical completes $15 million private placement - Caraco Pharmaceutical Laboratories
Caraco Pharmaceutical Laboratories reports record sales for 4Q and full year 2006 - Cerimon Pharmaceuticals
Cerimon Pharmaceuticals names James Welch as chief financial officer - More from this issue of Pharma Investments, Ventures and Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
